Clinical Trial Update: Combined Locoregional Treatment With Immunotherapy for Unresectable HCC. [Phase 1]

View source ↗

Summary

Phase 1 trial update evaluating combined locoregional treatment with immunotherapy for unresectable hepatocellular carcinoma; the study is currently active but …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Hepatic Carcinoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING